HilleVax, Inc.
HLVX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,328 | $1,983 | $5,428 | $20,165 |
| G&A Expenses | $5,657 | $5,621 | $5,951 | $6,215 |
| SG&A Expenses | $5,657 | $5,621 | $5,951 | $6,215 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $24,772 | $0 |
| Operating Expenses | $6,985 | $7,604 | $36,151 | $26,380 |
| Operating Income | -$6,985 | -$7,604 | -$36,151 | -$26,380 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,719 | $1,543 | $2,204 | $557 |
| Pre-Tax Income | -$5,266 | -$6,061 | -$33,947 | -$25,823 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,266 | -$6,061 | -$33,947 | -$25,823 |
| % Margin | – | – | – | – |
| EPS | -0.11 | -0.12 | -0.68 | -0.52 |
| % Growth | 8.3% | 82.4% | -30.8% | – |
| EPS Diluted | -0.11 | -0.12 | -0.68 | -0.52 |
| Weighted Avg Shares Out | 50,114 | 49,981 | 49,584 | 49,382 |
| Weighted Avg Shares Out Dil | 50,114 | 49,981 | 49,584 | 49,382 |
| Supplemental Information | – | – | – | – |
| Interest Income | $746 | $776 | $1,601 | $1,353 |
| Interest Expense | $0 | $0 | $0 | $1,853 |
| Depreciation & Amortization | $478 | $490 | $854 | $842 |
| EBITDA | -$4,788 | -$5,571 | -$33,093 | -$23,128 |
| % Margin | – | – | – | – |